Shares of multibagger stock Acutaas Chemicals surged over 13% on Tuesday, October 27, after the specialty chemicals manufacturer reported strong year-on-year growth in its September quarter earnings and raised its full-year FY27 revenue and margin guidance. The stock's latest rally added to its exceptional long-term performance, with shares delivering a return of nearly 599% over five years.
The company raised its FY27 revenue growth guidance to around 30%, from the earlier estimate of 25%, while increasing its EBITDA margin guidance to 38-40%. Improved revenue visibility and a robust order pipeline supported management's more optimistic outlook.
Acutaas Chemicals reported revenue of ₹437 crore for the September quarter, marking a 42.8% increase from ₹306 crore in the corresponding period last year.
Operating performance improved even faster, with earnings before interest, tax, depreciation and amortisation (EBITDA) climbing 86.3% year-on-year to ₹177 crore from ₹95 crore. EBITDA margin expanded sharply to 40.5%, compared with 31% a year earlier, supported by improved operating leverage and higher gross margins.
The pharmaceutical intermediates business continued to drive growth, while the specialty chemicals segment remained subdued. The company's contract development and manufacturing organisation (CDMO) operations and core advanced intermediates business also delivered robust growth during the quarter.